Jagson Pal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 13.22 Cr
- Company Age 46 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 80.80 Cr
- Revenue Growth 5.67%
- Profit Growth 36.42%
- Ebitda 32.40%
- Net Worth 21.42%
- Total Assets 15.73%
About Jagson Pal Pharmaceuticals
Jagson Pal Pharmaceuticals Limited. (JPPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 August 1978 and has a history of 46 years and six months. Its registered office is in South Delhi, Delhi, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 507789 and on the National Stock Exchange(NSE) under JAGSNPHARM.
The Corporate was formerly known as Jagson Pal Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 13.22 Cr.
The company has closed loans amounting to ₹80.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jagson Pal Pharmaceuticals Limited. India are Ashish Lakhotia as CFO and Abhishek Joshi as Company Secretary. Radhika Pereira, Prithipal Kochhar, Harsha Raghavan, and Three other members serve as directors at the Company.
Company Details
- Location
South Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L74899DL1978PLC009181
- Company No.
009181
- Stock Symbol
BSE : 507789 NSE : JAGSNPHARM
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1978
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Jagson Pal Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Gupta  | Managing Director | 16-Jul-2022 | Current |
| Ashish Lakhotia | CFO | 20-Feb-2024 | Current |
| Abhishek Joshi | Company Secretary | 13-Feb-2023 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Radhika Pereira | Director | 29-Jun-2022 | Current |
| Pallavi Gupta | Additional Director | 29-Jun-2022 | Current |
| Harsha Raghavan | Nominee Director | 29-Jun-2022 | Current |
Prithipal Kochhar  | Director | 29-Jun-2022 | Current |
| Debasis Nandy | Additional Director | 29-Jun-2022 | Current |
Financial Performance of Jagson Pal Pharmaceuticals.
Jagson Pal Pharmaceuticals Limited., for the financial year ended 2023, experienced modest growth in revenue, with a 5.67% increase. The company also saw a substantial improvement in profitability, with a 36.42% increase in profit. The company's net worth Soared by an impressive increase of 21.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagson Pal Pharmaceuticals?
In 2022, Jagson Pal Pharmaceuticals had a promoter holding of 68.72% and a public holding of 31.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Voith Paper Fabrics India LimitedPallavi Gupta is a mutual person
Tips Films LimitedRadhika Pereira is a mutual person
Suvinys Developers Private LimitedPrithipal Kochhar is a mutual person
Aresko Restaurants Private LimitedPrithipal Kochhar is a mutual person
Raipur Lodge Private LimitedPrithipal Kochhar is a mutual person
Onward Technologies LimitedHarsha Raghavan is a mutual person
Charges (Loans)
₹0
₹80.80 Cr
Charges Breakdown by Lending Institutions
- Punjab & Sind Bank : 60.90 Cr
- Others : 19.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2010 | Punjab & Sind Bank | ₹6.70 Cr | Satisfied |
| 26 Oct 2010 | Punjab & Sind Bank | ₹3.00 M | Satisfied |
| 26 Oct 2010 | Punjab & Sind Bank | ₹31.90 Cr | Satisfied |
| 28 Jun 2006 | Punjab & Sind Bank | ₹22.00 Cr | Satisfied |
| 28 Jun 2006 | Others | ₹19.90 Cr | Satisfied |
How Many Employees Work at Jagson Pal Pharmaceuticals?
Jagson Pal Pharmaceuticals has a workforce of 1012 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagson Pal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagson Pal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
